Topotecan and Melphalan for Retinoblastoma

PHASE3RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 11, 2021

Primary Completion Date

December 30, 2024

Study Completion Date

December 30, 2027

Conditions

RetinoblastomaChemotherapy Effect

Interventions

DRUG

Topotecan

Topotecan intraocular injection for chemotherapy in retinoblastoma

DRUG

Melphalan

Melphalan intraocular injection for chemotherapy in retinoblastoma

Trial Locations (1)

RECRUITING

Sun Yat-sen University, Guangzhou

All Listed Sponsors

lead

Sun Yat-sen University

OTHER